About the Company

CEO:
Itai Hayut
Partner:
Amir Lahat
Visit Our Website

Scopio develops next-generation digital microscopes, based on computational imaging breakthroughs, as well as a suite of dedicated image analysis tools. Their products enable dramatic clinical and research improvements in diverse areas such as cancer, hematology and cytology, while powering further innovation in areas such as academic research and drug discovery.

With the increasing attention of hematological disorders and malignancies, the accuracy and timeliness of peripheral blood smears results are critically important for timely diagnosis and effective treatment initiation. he peripheral blood smear (PBS) review is a powerful diagnostic tool that provides clinicians with information about a variety of disorders such as blood-related cancers, anemia, infections, and many other life-threatening medical conditions. Often, performing PBS analysis forces medical technicians to compromise on either field of view or resolution and requires physically transferring PBS slides to a microscope for manual review. Our new capability to automatically transfer PBS slides from Beckman Coulter’s DxH Slidemaker Stainer II to the Scopio X100HT platform removes the need for a technician to manually transfer the slides, resulting in lab efficiency for medical technicians, while Scopio’s Full-Field technology removes the need to revert to the microscope for manual review.

Dan Xu, Vice President/GM, Hematology and Urinalysis Business Units for Beckman Coulter
Back to ALL COMPANIES